Advanced Search
Contact | Corporate | Help

A Long-term Trial of OPC-34712 in Patients With Schizophrenia

Sponsors:
  • Otsuka Pharmaceutical Co., Ltd.
Phases:
  • Phase III
IndicationsAcronym:
  • Schizophrenia
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: OPC-34712
Enrollment:

Additional information about NCT01456897.


SourceSolution © 2008-2012